Efficacy and safety of intravitreal aflibercept (Eylea®) therapy using a proactive treat-and-extend regimen in neovascular AMD

Article

Download Supplement
Related Content
Site Logo

Is Artificial Intelligence (AI) the solution to saving ophthalmologists’ time?

June 5th 2024
Article
Site Logo

Updates From Angiogenesis 2022

February 11th 2022
Podcast
Site Logo

An ophthalmologist with personal experience has explored the impact of AI-driven solutions

March 1st 2024
Article
Site Logo

Updates from ASRS 2021

October 28th 2021
Podcast
Site Logo

iCare HOME tonometers optimize patient care

June 1st 2023
Article
Site Logo

Self-tonometry provides invaluable insights into IOP fluctuations

December 1st 2022
Article
© 2024 MJH Life Sciences

All rights reserved.